Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance

Masahiro Wakita1, Koyu Ito1,2, Kaho Fujii1

  • 1Research Institute for Microbial Diseases (RIMD), The University of Osaka, Suita, Japan.

Nature Aging
|January 29, 2026
PubMed

Insights

Senolytic drugs target senescent cells to combat aging and disease. Combining potent senolytics like ABT263 with strategies that induce mitochondrial stress enhances their efficacy and reduces tumor growth.

Area of Science:

  • Cellular and Molecular Biology
  • Aging Research
  • Oncology

Background:

  • Cellular senescence is implicated in aging and various diseases.
  • Senolytic drugs offer therapeutic potential by eliminating senescent cells.
  • The comparative efficacy and resistance mechanisms of senolytic agents require further investigation.

Purpose of the Study:

  • To systematically compare the efficacy of 21 senolytic agents.
  • To identify mechanisms of resistance to senolytic drugs.
  • To explore strategies for enhancing senolytic therapy effectiveness.

Main Methods:

  • Comparative analysis of 21 senolytic agents using a senolytic specificity index.
  • Investigation of senescent cell viability and mitochondrial integrity.
  • In vitro and in vivo studies assessing the impact of mitochondrial stress on senolysis.
  • Evaluation of ketogenic diet and SGLT2 inhibition in combination with senolytics.

Main Results:

  • ABT263 (Bcl-2 inhibitor) and ARV825 (BET inhibitor) were identified as the most effective senolytics.
  • Senolytic resistance is mediated by V-ATPase-dependent clearance of damaged mitochondria, maintaining mitochondrial integrity.
  • Inducing mitochondrial stress through metabolic workload, ketogenic diet, or SGLT2 inhibition potentiated ABT263 and ARV825 efficacy.
  • Combination therapy reduced metastasis and tumor growth in mouse models.

Conclusions:

  • Mitochondrial quality control is a critical factor in resistance to senolysis.
  • Targeting mitochondrial stress can overcome resistance to potent senolytic drugs like ABT263 and ARV825.
  • This provides a framework for developing combination senotherapies to enhance treatment outcomes in aging and cancer.

Related Concept Videos

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.0K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
595
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.2K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
648
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
224
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
194